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Summary  
World Health Organization (WHO) recommends directly observed treatment short course 
(DOTS) strategy to control tuberculosis (TB). It aims to detect 70% of new smear-positive 
cases and cure 85% of them. Implementing the DOTS strategy has improved the case 
detection rate (CDR) and treatment success rate (TSR) in many settings.   
 
We reviewed the performance of TB control programme of the southern Ethiopia. Low 
CDR mainly because of inability to access the health service was the limit. We also 
explored alternatives that could improve access to the health service, its cost-
effectiveness; estimated the recurrence rate and mortality in successfully treated TB 
patients under DOTS strategy and the rate of human immunodeficiency virus (HIV) 
infection in TB patients.   
 
In ten years, TB control programme of southern Ethiopia has improved the case detection 
(from 22% to 45%) and treatment success (from 53% to 85%). However, the target of 
CDR seemed unachievable. Some of the reasons were low health service coverage, 
shortage of general health workers (GHWs), HIV epidemic and poor socioeconomic 
conditions. Ethiopia launched community-based programme that deployed huge number 
of health extension workers (HEWs) to the community. Nevertheless, the possible 
contribution of HEWs in TB control programme of Ethiopia has not been explored. 
 
We, therefore, employed community-based approach to identify alternatives that improve 
the performance of TB control programme. The HEWs were involved in sputum 
collection and providing directly observed treatment (DOT). This improved the CDR, 
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more significantly for women. This could be mainly because of the community-based 
sputum collection that had increased access to the diagnostic service. Moreover, 
community-based treatment improved the TSR of smear-positive patients (90%) 
compared with to health facility-based DOT (83%). This could be due to the improved 
access to the service that was created through the provision of DOT in the community 
where TB patients live, with in reachable distance. 
 
The decision to employ effective interventions by policy-and decision-makers depends on 
the available resources and existing supporting evidences. This is more important in 
resource-constrained settings with high disease burden. We, therefore, estimated the cost 
and cost-effectiveness of involving HEWs in providing DOT. In our study, treating 
smear-positive cases in the community reduced the total, patient and caregiver costs by 
62.6%, 63.9% and 88.2%, respectively.  
 
We also estimated the recurrence rate and mortality in TB patients cured under DOTS 
strategy and the rate of HIV infection in TB patients and the community. The rate of 
recurrence in smear-positive TB patients cured under DOTS strategy was 1 per 100 PYO 
(0.01 per annum). The rate of TB-HIV co-infection varied with the prevalence of HIV in 
the community. We found mortality rate of 2.5% per annum in successfully treated TB 
patients. The mortality was associated with sex, age and occupation.   
 
We have shown that the performance of TB control programme could be improved by 
involving HEWs in TB control programme as we found improved the CDR and TSR. 
Community-based DOT is economically attractive option to the patient, the household 
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and the health service. We recommend planned scaling up and implementation of 
community-based TB care in Ethiopia to improve the performance of National TB 
Leprosy Control Programme (NTLCP).  Currently the Federal Ministry of Health of 
Ethiopia has accepted and endorsed the implementation of community-based TB care by 
involving HEWs. National guideline for implementing community-based TB care is being 
developed to apply it at larger-scale in Ethiopia. 
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1.0. Introduction 
1.1. Tuberculosis epidemiology 
1.1.1 Cause, transmission and risk factors 
Tuberculosis (TB) is a chronic infectious disease mainly caused by mycobacterium 
tuberculosis (MTB). The main source of infection is untreated smear-positive pulmonary 
tuberculosis (PTB) patient discharging the bacilli. It mainly spreads by airborne route 
when the infectious patient expels droplets containing the bacilli. It is also transmitted by 
consumption of raw milk containing Mycobacterium bovis [1-3]. 
 
The risk of infection depends on the susceptibility of the host, the extent of the exposure 
and the degree of infectiousness of the index case [3-5]. Once an individual inhales the 
infectious aerosols, the bacilli lodge into the alveoli where it multiply and form a primary 
lesion [6].  Under normal condition, in most of the cases, the immune system either clears 
the bacilli or arrests the growth of the bacilli within the primary lesion in which case the 
host is said to harbor latent TB infection (LTBI). However, in 5 - 10% of the cases, the 
bacilli overwhelm the immune system resulting in a primary TB within a few months to 
years. In the rest, post-primary TB occurs when reinfection occurs or the LTBI is 
reactivated. The lifetime risk of developing active TB is 5 - 10 %.  It could be higher 
because of the underlying conditions (like human immunodeficiency virus (HIV) 
infection, diabetes and other medical conditions that suppress immunity) and poor 
socioeconomic status [3, 7].  
 
Although TB affects many parts of the body, it mainly affects the lung. Its clinical 
presentation, therefore, depends on the site of infection, the organ affected and its 
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severity. Patients with PTB present with pulmonary symptoms (like productive cough, 
haemoptysis, chest pain and shortness of breath), constitutional symptoms (like fever, 
poor appetite, weight loss, night sweats and anorexia) and other symptoms depending on 
the site of the infection [8-11]. Understanding of the symptoms is important to inform the 
community about the symptoms to seek medical advice and to inform health workers in 
order to increase the index of suspicion to easily pick suspects and detect tuberculosis 
cases presenting to health institutions.  
 
Early detection of the cases and prompt treatment are crucial for TB control. TB diagnosis 
mainly depends on the clinical presentation of the disease and identification of the 
offending bacilli. Many TB diagnostic tests are available although no single diagnostic 
test for TB exists that can be performed rapidly, simply, inexpensively, and accurately as 
a stand-alone-test. Thus, the diagnosis of active TB is a clinical exercise; and sputum 
microscopy remains the mainstay of diagnosis because of its availability, operational 
feasibility and ability to identify the highly infectious forms of TB, the smear-positive 
PTB cases [12-14].  
 
The significance of TB diagnosis is high if and only if it is complemented by prompt 
treatment. If not treated in the earliest five years, 50% of PTB cases die, 25% self cure 
and 25% remain sick and infectious. Untreated smear-positive PTB patient can infect 10 -
15 people per year on average [15]. Thus, treatment of TB is not only a matter of treating 
the individual patient, but also is an important public health intervention. Treatment is the 
centerpiece of TB control and can reduce the risk of infection if implemented with 
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adequate coverage and acceptable quality [16, 17]. So far, DOTS remains a cost-effective 
intervention to control TB [7, 18, 19].   
 
1.1.2. Morbidity and mortality  
TB has been a scourge of humanity throughout recorded history. Even today after the 
availability of effective drugs for more than half a century, it is a major cause of 
morbidity and mortality worldwide. One-third of world’s population is estimated to be 
infected with MTB [6, 20]. There were about 9.27 million new TB cases (including 4.1 
million new smear-positive cases) and 1.3 million deaths from TB in 2008. There 
were about 11.1 million prevalent TB cases and half million multidrug resistant (MDR) 
TB cases (resistance at least to isoniazid and Rifampcin) in the world. 95 % of TB cases 
and 98% of TB deaths occurred in developing countries [21, 22]. TB also is a leading 
infectious cause of death among women in the reproductive age group and affects the 
productive segment of a population[23]. TB is the sixth cause of mortality (2.5%) next to 
HIV infection and accounts for 26% of preventable deaths in the world [21, 24-26].  
 
1.1.3. Risk factors of acquiring tuberculosis 
Age 
The risk of acquiring TB infection increases with age from infancy to early adult life, 
probably, because of increasing number and frequency of contacts [27]. TB is mainly a 
disease of adults in the age group of 15 - 49 years. In a population where the transmission 
has been stable or increasing, the incidence rate is higher in children mostly because of 
recent infection or reinfection. As transmission falls, the case load shifts to older adults 
mainly because of  reactivation of LTBI at later ages [14].   
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Gender  
Reports show that men account for high proportion of notified TB cases than women [28, 
29]. This was explained by sex ( biological determinant - progression from TB infection 
to disease is likely to be faster for women compared with men in their reproductive years) 
and gender (socio-cultural determinants influencing access to TB care leading to 
differential access to health care (like economic problem, inability to make decisions, 
poor health seeking behaviour and stigma ) that compromise the women’s ability to utilize 
the available health service [11, 30-36]. In addition, higher risk of HIV infection among 
women makes them susceptible to develop active TB. TB is the leading infectious cause 
of death in young women in developing countries [35, 37, 38]. This could be worse in 
settings with  health services insensitive to gender-specific needs [39]. Studies that 
consider the interplay of biological, socio-cultural and health system determinants of sex 
and gender-based differences are needed to understand how and why women are affected. 
 
Residence  
More TB patients were reported from urban than rural areas because of overcrowding, 
poverty and HIV infection [40]. In contrast, the presumed lower risk of TB infection in 
rural settings could be misleading and should be cautiously taken in high burden 
countries. In the rural settings, access to the health service is limited; health seeking 
behaviour is poor and the living condition favour disease transmission. As a result, 
understanding the burden of TB in rural areas will have a wider implication for TB 
control in such settings [41, 42].  
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Socio-economic conditions   
TB has been associated with factors linked to socioeconomic deprivation: poverty, 
overcrowding and malnutrition. The magnitude of  TB is high among the poor, displaced, 
homeless, drug addicts, elderly, malnourished and women [14]. The association between 
TB and poverty was shown by the decline in TB burden with the improved living 
condition in developed countries prior to the introduction of treatment. Improved living 
condition was also found to reduce the risk of infection from 4 - 6 % per annum. In 
contrast, the resurgence of TB in developing countries as the living condition worsens 
shows its association with poor living conditions. TB was also found to disproportionately 
affect the poor [43-45]. Therefore, free diagnosis and treatment was offered to TB patients 
(mainly to smear-positive PTB cases) to reduce the economic burden for seeking 
diagnosis and treatment and treat the highly infectious cases [46]. However, limited 
access to the service because of the poor socioeconomic condition of the patients and their 
households has reduced the utilization of the available service [42, 46-51]. Thus, 
interventions that improve access to health service need serious consideration.  
 
1.2. Tuberculosis and HIV co-infection 
A complex interaction exists between TB and HIV infection. HIV increases the risk of 
infection, as it reactivates LTBI and increases the progression to active disease.  TB-HIV 
co-infection has fatal consequences as TB becomes the leading cause of death in HIV 
infected individuals and patients with acquired immunodeficiency syndrome (AIDS). HIV 
lowers the host’s immune response to MTB. The lifetime risk of developing active TB in 
HIV infected individuals is 10% per year compared with lifetime risk of 5 - 10% in 
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individuals without HIV. As a result, the TB case notification rate (CNR) has increased 
four to six fold in sub-Saharan Africa [52-54].  
 
HIV affected the performance of TB control programmes by increasing the number of TB 
cases and by compromising the treatment outcomes. It created a huge challenge to the 
already overstretched and under staffed health system in high burden countries. It reduced 
the proportion of smear-positive cases; and increased the rate of treatment failure, 
defaulter and death, which in turn compromised the progress towards achieving the 
targets recommended for TB control under DOTS strategy.  
 
Globally 1.37 million TB cases (14.8% of 9.27 million cases) were co-infected with HIV. 
70% of TB-HIV co-infections occurred in countries with high burden of TB. Moreover, 
half million deaths occurred in HIV infected people due to TB which accounted for a 
quarter of deaths among HIV positive people [21, 55-58]. There is an epidemiological and 
clinical association between the two diseases. Therefore, TB-HIV collaboration is an 
appropriate intervention to improve TB case finding in HIV infected individuals and 
reduce the risk of HIV infection in TB patients [6, 59-62].  
 
1.3. Global tuberculosis control 
History of TB control started from attempts of treating unidentified cause to  treating 
cases infected with the bacilli, from no remedy to effective treatment, from compulsory 
isolation to chemical isolation (treating infectious cases with anti-TB drugs), and from 
vertical to integrated approach where the service delivery was progressively decentralized 
to peripheral health institutions in the  communities [63, 64].     
Improving Tuberculosis Control in Ethiopia 
 7 
Daniel Gemechu Datiko 
Robert Koch’s identification of the bacilli and the proposal to isolate patients was 
followed by compulsory isolation of the patients as the main principle of TB control. This 
included social support and contact examination in TB clinics (that were accessible and 
open at convenient time for the patients) [65, 66].  
 
After the introduction of effective treatment, TB control was organized as a vertical 
programme staffed with health workers particularly assigned to run the programme. This 
reduced  the annual risk of infection by 5 -13% in developed countries due to the available 
resources and  improved general living conditions [67]. However, similar results were not 
achieved in developing countries due to the associated high cost [68]. Hence, TB control 
was integrated into general health service to ensure effective and efficient use of resources 
[69, 70].  However, lack of technical efficiency by the GHWs, neglect of TB control 
activities, health sector reform (that resulted in collapse of TB structure because of hasty 
implementation or lack of appropriate attention to TB control) and resurgence of TB due 
to HIV epidemic weakened the TB control efforts [71, 72]. This was also complicated by 
socioeconomic deterioration: increased poverty, malnutrition and overcrowding.   
 
The affordability of rifampicin, poor treatment adherence and high TB burden paved way 
to the introduction of DOTS strategy [73, 74]. The components of the strategy are 
government commitment to ensure lasting and comprehensive TB control, case detection 
by sputum smear microscopy among self-reporting symptomatic patients, standardized 
short course chemotherapy using six to eight months treatment regimens, regular and 
uninterrupted supply of anti-TB drugs and standardized recording and reporting system 
[64, 75].  
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DOTS strategy aims to detect 70% of new smear-positive cases and to cure 85% of them. 
Epidemiological modelling suggested that achieving these targets will reduce TB 
incidence, prevalence of smear-positive cases and the number of infected contacts [14, 
76]. Decentralization of DOTS to peripheral health facilities has increased the number of 
TB cases that were detected and treated [77] even in settings with high HIV infection and 
MDR TB [18, 78]. However, its effectiveness was limited in settings with low health 
service coverage.  
 
To improve TB control efforts, the Stop TB partnership further envisioned eliminating TB 
as a public health problem (one smear-positive case per 106 population) and, ultimately, to 
achieve a world free of TB. The partnership promotes TB control as an element for 
health-system development, a basic human right, and an integral part of poverty 
alleviation strategies [6, 60-62]. Stop TB partnership, therefore, advocates comprehensive 
TB control approach that includes providing  high quality DOTS expansion and 
enhancement, addressing TB-HIV, MDR TB and address the needs of the poor and 
vulnerable people (women, children, prisoners, migrants and ethnic minorities), 
strengthening the health system, engaging all care providers, empowering TB patients and 
the community with partnership, and enabling and promoting research to alleviate human 
suffering [79]. 
 
1.4. The health system of Ethiopia 
1.4.1. General background of Ethiopia  
Ethiopia is a located in East Africa. It covers an estimated area of 1.1 million km2. The 
Government of Ethiopia has nine ethnic-based administrative regions, which are referred 
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to as Regional States and two Federal City Administrations. There are 611districts and 
15000 kebeles (lowest administrative unit with an average population of 5000 people) 
[80]. Ethiopia has a population of about 76 million people, of which 85% lives in rural 
areas. It has huge topographic variations ranging from the lowest 116 meters below sea 
level to 4, 620 meters above sea level. Most of the population lives in highland areas on 
subsistence farming.  
 
1.4.2. Health service in Ethiopia  
General health service  
The National health policy of Ethiopia emphasizes the development and provision of 
equitable and acceptable health service to the people.  Under this provision, the 
Government of Ethiopia follows a four-tier health service with a major emphasis on 
community-based health services. Primary health care unit (a health centre and five 
satellite health posts) is the lowest unit in the health system (Figure 1).  Health centres 
provide curative and preventive health service while health posts mainly focus on disease 
prevention and health promotion activities and selective curative services in the 
community. 
 
Community-based initiative: Health Extension Programme  
In year 2004, the Government of Ethiopia launched a community-based initiative under 
health extension programme (HEP) with an emphasis to establish reflective and 
responsive health delivery system to the people living in rural areas. This was 
accompanied by accelerated health post construction in each kebele. HEP programme 
focuses on promoting health and providing preventive and selected curative services to 
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ensure equitable access to the community under three major categories: disease 
prevention and control, family health service, hygiene and environmental sanitation,  and 
health education and communication as a cross cutting issue [81, 82]. 
 
The local health authorities in consultation with kebele leaders select two women from 
each kebele, who have completed 10th grade. The women receive one-year training before 
they are placed as HEWs in their respective kebeles. TB control is included in the training 
of HEWs as one of the components under Disease Prevention and Control. HEWs are 
responsible to provide health education, identify and refer TB suspects, trace defaulters 
and ensure treatment adherence.  
 
Assigned to health post, HEWs spend about three-fourth of their time on outreach 
activities in the communities, the kebele in particular. Each HEW is responsible for 500 - 
1000 households in each kebele. They receive salary from the government and are 
accountable to health centre and the kebele administration [83, 84]. However, their 
contribution to TB control has not been evaluated. The health system, administrative 
hierarchy and referral system is shown in figure 1. 
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Figure 1 - The health system of Ethiopia  
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1.4.3. Tuberculosis control in Ethiopia  
TB is among the leading causes of morbidity and mortality in Ethiopia [80]. The NTLCP 
was started in 1992. Ethiopia adopted the WHO recommended DOTS strategy in 1995. 
Since then TB control efforts have been decentralized to public health facilities (hospitals, 
health centres and health stations) where GHWs are responsible for the diagnosis and 
treatment of TB.  [80, 83, 85].    
 
Ethiopia has one of the highest TB burden in the world. The annual incidence and 
prevalence of all forms of TB was 378 and 579 per 105 populations, respectively [21]. 
DOTS is implemented in public health facilities in hospitals and health centres [80].   
The CNR for all forms TB was 155 per 105 populations. The incidence of smear-positive 
cases was 163 cases 105 populations. The CNR and CDR of new smear-positive cases was 
46 per 105 populations and 28 %, respectively. The TSR, the proportion of patients who 
were cured and completed treatment, was 84 % [21].  
 
1.4.4. Tuberculosis control in the southern Ethiopia  
Southern Nations, Nationalities and People’s Regional State (SNNPRS) is one of the 
Federal States of Ethiopia. It has a population of about 15 million. Ninety-three per cent 
of its population lives in the rural areas. The health service coverage and user rate is about 
73.5 % and 32 %,  respectively [80].  
 
The SNNPRS Health Bureau started DOTS in three zones and four health facilities as a 
vertical program in 1995. Later, the programme was integrated into the general health 
service, and decentralized to zones, districts and health facilities (hospitals, health centres 
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and health stations). Over ten years, implementation the DOTS strategy tripled TB case 
notification (45 to 143 per 105 population), doubled the case detection rate (22 to 45%), 
increased the treatment success rate (from 53 to 85%), reduced the defaulter rate (from 26 
to 6%) and treatment failure rate (from 7 to 1%) [86]. 
 
TB remains the leading cause of morbidity and mortality in southern Ethiopia. It was 4th 
cause of total admission, 5th cause of female admission and 5th cause of admission in 
children less than five year. It was the 3rd cause of inpatient deaths, 2nd cause of deaths in 
women and 6th cause of death in children less than five years [80].   
 
1.5. Rationale for the present study 
Over the last two decades, the load of TB has increased in sub-Saharan Africa mainly 
because of HIV infection. This has compromised the already overstretched health services 
due to the associated morbidity. The implication is more in settings with low health service 
coverage and shortage of health workers [6, 62].    
 
DOTS strategy advocates passive case finding and provision of DOT under the direct 
observation of GHWs or treatment supervisors. Passive case finding mainly serves those 
who have better socioeconomic status (better knowledge and health seeking behaviour) and 
geographic access to health facilities. This affects the poor and patients living in rural and 
remote areas leading to delay in presentation and disease transmission [42, 44]. Moreover, 
seeking diagnosis and treatment in health facilities is costly and difficult for TB patients and 
their families [47, 87-89]. In TB patients who have accessed the service, adherence and 
completion of treatment remains a challenge to successful completion of treatment. 
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Therefore, alternative approaches that improve access to diagnosis and treatment are needed 
[90-95].  
 
Ethiopia has one of the highest TB burden in the globe. TB is among the leading causes of 
morbidity and mortality. Over the last two decades implementing DOTS strategy has 
increased the number of TB patients diagnosed and treated. However, the CDR for smear-
positive patients remained far below the target despite increasing number of health workers 
and health facilities providing DOT. This was mainly because of the limited access to the 
health service. However, decentralization and performance of DOTS strategy in the era of 
HIV epidemic has not been documented in Ethiopia.  
 
In 2004, the government of Ethiopia introduced a community-based initiative under HEP to 
provide health service in each kebele by a new cadre of health workers. However, the role of 
HEWs in TB control has not been explored. Therefore, we aimed to measure the 
performance DOTS, identify the role of HEWs in improving the performance of the TB 
control programme and its cost-effectiveness to implement in resource-constrained Ethiopia. 
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2.0. Study aims  
2.1. Aim  
The aim of this research was to improve the performance of TB Control in Ethiopia  
 
2.2. Objectives  
1. To find out ten-year performance of TB control programme in southern Ethiopia  
2. To estimate the rate of HIV infection in TB patients and its association with the 
prevalence of HIV in the community  
3. To find out if involving HEWs in TB control improves the CDR and TSR of smear-
positive patients 
4. To compare the cost and cost-effectiveness of treating smear-positive  patients by 
HEWs in the community compared to treatment by GHWs in health facilities  
5. To determine the recurrence rate in smear-positive patients cured under DOTS 
6. To determine mortality in TB patients after successful treatment  under DOTS 
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3.0. Methods  
3.1. Study area and population 
3.1.1. Study area  
Ethiopia is the third largest and populous country in Africa (Figure 2).  It covers an area of 
1.1 million km2 and has a population of 76 million people.  85% of the population lives in 
rural areas.   It has nine regional states and two city administration. It is undergoing 
enhanced health facility construction and training of health workers to improve the delivery 
of health service to the community.  
 
Ethiopia is a poor country with one of the worst health indicators in the world [96]. 
Communicable diseases and nutritional deficiencies are the main causes of morbidity and 
mortality. However, the country is making remarkable changes by expanding health 
service delivery and extending affordable primary health care to the community [80, 97].  
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Table 1 selected demographic and health indicators for Ethiopia   
Indicators  Rates 
2008 2009 
Life expectancy at birth [98] 56 55.4 
Incidence of TB all forms per 105 379 378 
Incidence of smear-positive TB per 105 168 163 
Prevalence of TB per 105 643 579 
Case detection rate of new smear-positive cases   27% 28% 
DOTS treatment success rate per 105 84% - 
TB mortality per 105 84 92 
Adult HIV prevalence (urban/rural) [99] 3.0(9.5/1.6) 2.9(9.4/1.5) 
TB HIV co-infection (new TB cases) 6.3% 19% 
MDR TB new(retreatment) 1.6% (12%) - 
 
SNNPRS is the third largest and populous region in Ethiopia. It is located in the south-west 
part of the country. It shares international borders with Sudan and Kenya. It covers 118, 000 
square km (10% of national area). It has a population of about 15 million (20% of the 
national population). It has 13 zones, one city administration and eight special districts. 93% 
of the population lives in rural areas. The health service coverage and user rate was 73.5 % 
and 32%, respectively.  TB treatment is provided in all hospitals and health centres (DOTS 
coverage was 100% in hospitals and health centres). However, only 16% (354/2230) of 
health facilities provide treatment to TB patients inclusive of health posts.  Nevertheless, 
DOT has not been implemented in health posts and HEWs do not provide DOT to TB 
patients.  
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Sidama zone is located in SNNPRS. It has 19 districts and two towns. It has about 3.2 
million people in an area of 6,981 square km. It is one of the most densely populated 
zones of the region with a population density of 463 people per square km. Fifty-five per 
cent of the population lives at a two-hour walking distance from the health facilities. Dale 
and Wonsho are rural districts in Sidama zone located about 50 kms from Hawassa, the 
SNNPRS capital. There are 51 kebeles in the two districts.  
 
Figure 2 - Map of the study area  
 
Ethiopia
SNNPRState
Sidamazone
DaleandWonshodistricts
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3.1.2. Study population 
The SNNPRS Health Bureau started implementing DOTS strategy in 1995. TB control 
programme was decentralized to hospitals, health centres and health stations. TB case 
finding and treatment outcome reports were complied on quarterly basis. TB patients 
reported from 1995 - 2004 were enrolled to measure the performance of TB control 
programme of southern Ethiopia (Paper I).   
 
In 2005, after implementation of DOTS strategy for ten years, the prevalence of HIV and 
its association with the rate of TB-HIV co-infection was estimated by enrolling pregnant 
women and TB patients in the southern Ethiopia. This was performed as part of regular 
HIV surveillance conducted by the SNNPRS Health Bureau. Paper II was based on the 
data obtained from TB patients and pregnant women attending health facilities for 
antenatal care (ANC) for the first time during the study period.  
 
In 2006, TB patients who were successfully treated (declared cured or treatment 
completed) under DOTS strategy in two rural districts of Sidama zone (Dale and Wonsho) 
were retrospectively followed to the first cohort that received DOT (Paper V & VI).   
 
Smear-positive patients from intervention and control kebeles were enrolled in a 
community randomized trial conducted in the two rural districts of Sidama zone. TB 
patients identified from intervention and control kebeles received DOT. These patients 
were followed until they completed treatment for TB (Paper III). Prospectively cost data 
was collected for these patients, caregivers and health workers to find out the cost and 
cost-effectiveness of providing DOT by HEWs (Paper IV). Smear-negative and EPTB 
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cases were excluded from the study. However, they received the treatment available in 
intervention or control kebeles (see additional results - 5, table - 3). 
 
3.2. Study design 
The main study design was community randomized trail (Paper III). In this study, 51 
kebeles from two rural districts were randomly allocated to intervention and control 
groups. Kebele was the unit of randomization. We used table of random numbers for 
allocation. TB patients diagnosed from the intervention kebeles were started on DOT under 
the direct observation of HEWs while patients from the control kebeles received health 
facility-based DOT under the direct observation of GHWs. Cost data was prospectively 
collected for these patients along the main study to estimate the cost and cost-effectiveness 
of providing DOT under the two treatment options (Paper IV).   
 
In Paper II, TB patients and pregnant women were enrolled in a cross-sectional study to 
find out the rate of TB-HIV co-infection and the prevalence of HIV in southern Ethiopia. 
TB patients and pregnant women presenting to the health facilities were consecutively 
enrolled after obtaining informed consent. HIV testing was done (from the remaining 
serum after routine blood test for pregnant women and from sample collected for 
surveillance of HIV in TB patients) at the Centre for Health Research Laboratory (CHRL) 
at SNNPRS Health Bureau.    
 
Paper I reports a cross-sectional study conducted to assess the ten-year performance of the 
TB control programme based on the reports compiled at the SNNPRS Health Bureau. We 
also conducted a retrospective cohort study to find out the recurrence and mortality rate in 
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TB patients after successfully receiving treatment under DOTS strategy. TB patients who 
were declared treatment completed or cured were traced to their home (Paper V & VI).  
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Table - 2 Summary of the studies conducted: the design, population and the study period   
Paper  Titles  Study design  Study population  Study period  
I. Ten-year experiences of TB  
control in southern Ethiopia  
 
Cross sectional  136 572 TB patients  
 
1995 - 2004 
II. The rate of TB HIV co-
infection  
Cross sectional  1308 TB patients  
4199 Pregnant women  
2005 - 2006 
 
 
III. HEWs improved the case 
detection and treatment  
Community 
randomized trial  
318 TB patients  2006 - 2008 
IV. Cost-effectiveness of TB 
treatment  
Community 
randomized trial  
229 TB patients, 30 
HEWs, 10 GHWs 
2006 - 2008 
V. TB recurrence in smear-
positive patients  
Retrospective 
cohort study  
 
368 TB patients  1998 - 2006 
VI. Mortality in successfully 
treated TB patients 
Retrospective 
cohort study 
725 TB patients  1998 - 2006 
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To achieve the targets of DOTS strategy, understanding the transmission of the disease, 
the progress from infection to disease and effective control measures that early identify 
the cases, cure the disease and maintain disease free survival of the cases and the 
community is important. Therefore, increasing the awareness of the community in 
prevention of the transmission, recognizing the symptoms and seeking diagnosis should 
be complemented by the ability of health workers to identify the cases, provide prompt 
treatment and encourage the patients to adhere to the treatment. Studies and intervention 
that address these issues will be of great significance to TB control.  
 
The aim of our study as described earlier was to improve the performance of TB control 
in Ethiopia. We tried to address the challenges of TB control in southern Ethiopia in 
relation to the patient, community and health system. To put our study in context we have 
depicted how our studies fitted into the public health model of TB control adopted from 
simulation model of case-finding and treatment in tuberculosis control programme [100, 
101]. We focused on improving symptom recognition, health seeking, diagnosis, 
treatment compliance, its cost-effectiveness and post-treatment consequences as shown 
below (Figure 3).    
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Figure 3 - The schematic presentation of the studies in the public health model of TB 
control  
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3.3. Data collection and management  
3.3.1. Data collection tools and methods   
NTLCP uses standard recording and reporting formats to monitor TB control efforts. Case 
finding and treatment outcome data were complied and reported on quarterly basis from 
lower to higher administrative levels (from District Health Offices  Zonal Health 
departments  Regional Health Bureaus  Federal Ministry of Health) and copies of the 
reports were kept at all levels for official documentation ( Figure - 1 ). Ten-year TB 
programme review (Paper I) was based on the copies of reports remaining at SNNPRS 
Health Bureau.    
 
In Paper II, TB patients and pregnant women were enrolled from health facilities to find 
out the rate of HIV infection. Trained laboratory technicians and GHWs collected the data 
using a pretested questionnaire prepared for HIV surveillance among pregnant women 
and TB patients.   
 
In paper III, smear-positive patients from intervention and control kebeles were registered 
in the health facilities and were treated under the two treatment options: under the direct 
observation of GHWs or HEWs. During supervision, district TB experts transcribed the 
list of patients from unit TB registers in the health facilities to district TB registers. They 
also cross-checked the sputum results of smear-positive cases in the TB unit register 
against the smear results recorded in the laboratory register. TB case finding and 
treatment outcome data were quarterly reported from district TB register using standard 
reporting formats.  
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In Paper IV, smear-positive patients from intervention and control kebeles were 
prospectively enrolled and cost data was obtained using a structured questionnaire. 
Trained GHWs and HEWs interviewed the patients and caregivers about the travel time, 
transport cost and costs related to visit to health facilities or health posts for treatment. 
Similarly, the cost data for HEWs and GHWs was collected by trained data collectors 
from the two districts. The salary of established positions, budget expenditures, medical 
equipments, vehicles and buildings were obtained from health facilities, district health and 
finance offices. Joint costs were shared based on the proportion of time used for TB 
control. Capital items were annualized using 30 years for buildings, 10 years for 
equipments and 5 years for motorbikes as an expected useful life. The base year for 
valuing cost was 2007, and the applicable exchange rate was 8.6 Ethiopian birr for 1 
USD.  
 
In Paper V & VI, TB patients who were treated since the start of DOTS in the study area 
were retrospectively followed in the two districts. The lists of TB patients who were 
declared treatment completed or cured were obtained from unit TB registers in the health 
facilities and district TB registers. HEWs collected the data about the current status of the 
patients if they were alive or dead. This was done by taking registered history of TB 
patients from unit registers for prior successful treatment in health facilities and recent 
history of TB was obtained by making house-to-house visits. The data about recurrence or 
rediagnosis of TB after successful treatment was confirmed by cross-checking with the 
list of TB patients on unit or district TB registers.   
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3.3.2. Study management 
The study team consists of HEWs, GHWs, district HEP experts and TB programme 
experts at Districts, Zone and Region including the principal investigator and the 
supervisor.  
 
The HEWs were responsible for case finding and provision of DOT in an intervention 
kebeles. They also conducted house-to-house visit to collect data about post-treatment 
follow-up of TB patients and cost data for patients receiving treatment in their kebeles.  
 
The GHWs were responsible for supervising the TB control activities conducted by 
HEWs, registration of TB patients in the unit TB register, provision of drugs and supplies 
to the health post and providing DOT for patients receiving treatment in health centres. 
 
The district HEP experts were responsible for coordinating the activities of HEWs in TB 
control; and District TB programme experts were responsible for providing drugs and 
supplies, coordinating the activities, ensuring the completeness and consistency of the 
recording and reporting in the health facilities and report the quarterly performance of 
district TB control programmes. TB and Leprosy Control Programme experts from zone 
and region also conducted supportive supervision to the districts, health facilities and 
kebeles.   
 
The principal investigator was responsible for organizing and supervising the overall 
conduct of the studies and reports the activities to the supervisor who also facilitated the 
administrative and technical issues to accomplish the work and conducted the field visits. 
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3.3.3. Data safety and quality assurance 
Effective delivery of an intervention requires both that the providers adhere to the  
intervention procedure and that the participants cooperate appropriately [102]. To ensure 
this, HEWs, GHWs and TB programme experts were trained about community-based TB 
care and its implementation. The trainees received copies of training documents and field 
guides prepared in Amharic (official language of Ethiopia) to use it as a reference. This 
was accompanied by supportive supervision: GHWs supervised HEWs, reviewed the 
conduct of case finding and treatment, and checked the completeness and accuracy of the 
cost and post-treatment follow-up data. They also crosschecked patient data by making 
home visits and interviewed the patients in their kebeles.  
 
District TB programme experts conducted supportive supervision to health facilities and 
kebeles. The district programme experts checked the completeness and accuracy of the 
data, the recording and reporting of patients, the patient follow-up and the availability of 
resources. The experts also cross-checked the data from unit TB register with the 
laboratory register in the same health facility, the data from health facilities against the 
data from the kebeles and the patients. They also collected slides from diagnostic units for 
blind rechecking as part of external quality assurance and it was done at CHRL as per the 
recommendation of the NTLCP. The district health office reviewed the community-based 
TB care and other health activities on quarterly basis. Regular supervision was also 
conducted by the investigator and TB programme experts from the SNNPRS Health 
Bureau. The six months performance of the community-based TB care was conducted in 
Yirgalem.   
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Definition of terms  
TB Diagnosis, classification, case definitions and treatment outcomes were dealt with in 
individual papers. Some important terms are defined below.    
Failure: refers to a patient who remains or becomes smear positive at 5th month or later. 
Cured: refers to smear-positive patient who is smear-negative at the last month of  
treatment and at least on the previous occasion (at 2nd or 5th month). 
Treatment completed refers to a smear-positive patient who completed full course of  
treatment but does not have smear result at 7th month of treatment or does not fulfil the 
criteria to be classified as failure; or smear-negative and EPTB patients who completed 
the full course of treatment.  
Case detection rate: is the number of smear-positive patients detected of the estimated 
new smear-positive patients expressed in percentage. 
Treatment success rate: is the number of TB patients cured or treatment completed of the 
total TB cases reported expressed as percentage  
Relapse: refers to rediagnosis of smear-positive TB in patients after successful treatment.   
Recurrence: refers to rediagnosis of TB in patients who were declared cured or treatment 
completed in the past with or without smear positive result. It also included relapse cases. 
 
3.4. Study outcome measures  
The main study outcomes were CDR, TSR, proportion of HIV infected, mortality, 
recurrence of TB and cost per patient successfully treated.    
 
TB patients were classified into smear-positive, smear-negative and EPTB cases based on 
the smear result and the site involved. The treatment outcomes were cured, treatment 
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completed, default, failure, transfer out and died (appendix I & II).  In Paper  I, CDR and 
TSR were used to measure the performance of TB control programme as recommended 
by WHO [77]. 
 
In Paper V & VI, recurrence and mortality were used to measure the post-treatment 
condition of the TB patients. In Paper II, HIV test results were done using ELISA test. A 
societal perspective of cost estimation was used to find out the average cost per patient 
successfully treated (Paper IV).  
 
3.5. Sample size and statistical analysis  
For the community randomized trial, we used the CDR of 41% (an average of previous 
three years from 2003 - 2005 for the study area) [additional results -1, table - 1]. We 
estimated  the number of clusters needed on the basis that community-based case finding 
to increase the CDR by 30% using power of 80%, 95% confidence interval and 
accounting for 30% loss to follow-up. Based on the principle of allocating unequal 
clusters, 21 kebeles were assigned to control while 30 were allocated to intervention 
groups. TB patients who received treatment in the study area were included in the cost-
effectiveness study (Paper III & IV). As indicated in the individual papers, we enrolled 
and analyzed the available data as a whole and the number of patients evaluated was large 
enough for multiple comparisons (Paper I, II, V & VI). 
 
Microsoft Excel and SPSS for Windows 14 were used for data entry and analyses. 
Independent t-test and one way analysis of variance were used to compare the mean CDR 
and TSR for cluster level values and to determine the intraclass correlation coefficient 
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(Paper III), respectively. Average cost of treating smear-positive patients was divided by 
the number of patients treated successfully. One way sensitivity analysis was done to 
determine the cost-effectiveness of the intervention (Paper IV) 
 
Logistic regression analysis was used to estimate the effect of predictor variables on the 
rate of HIV infection among TB patients and pregnant women. Linear regression analysis 
was used to estimate the amount of variation explained by predictor variables (Paper II).   
 
Kaplan-Meier and Cox Regression method were used to evaluate event free (death or 
recurrence) survival and the relative effects of selected variables, respectively. Log rank 
test and hazard ratios were used for statistical significance. We calculated SMR using 
indirect standardization method (Paper V).  
  
3.6. Ethical considerations 
The Ethical Review Committee of the SNNPRS Health Bureau approved the studies. In 
consultation with the NTLCP, discussion was held with TB programme experts at zone, 
districts and health facilities about community-based TB care. Subsequently similar 
discussion was held with kebele leaders and we obtained community consent. Enrolment 
of the study participants was done after obtaining informed consent from individual study 
participants. The participants were also informed about the right to withdraw from the 
study without compromising their future care. PTB suspects that were smear-negative for 
acid fast bacilli were given free antibiotic treatment as part of diagnostic work up 
recommended by the NTLCP. In Paper II, study participants who wanted to know their 
Improving Tuberculosis Control in Ethiopia 
 32 
Daniel Gemechu Datiko 
HIV status were advised to visit the voluntary counselling and testing unit in the same 
health facility or in the nearby.    
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4.0. Synopsis of the Papers  
4.1. Paper I: Ten-year Experiences of Tuberculosis Control Programme in Southern 
Region of Ethiopia  
 
Implementation of the DOTS strategy started in 1995. It was decentralized to zones, 
districts and health facilities. Monitoring and evaluation is one of the components of the 
DOTS strategy to understand its performance. We aimed to find out the effectiveness 
decentralization on TB case finding and treatment outcome in southern Ethiopia. 
 
The result of the study was based on the official reports of TB control programme over 
ten years. The diagnosis and treatment, case notification and treatment outcome reports 
were based on the recommendations of NTLCP. 
 
In 2004, 94% of the health facilities (hospitals, health centers and health stations) 
implemented the DOTS strategy. 136 572 cases were registered in ten years; of these, 
47% were smear-positive, 25% were smear-negative and 28% had EPTB. The smear-
positive case notification rate increased from 45 to 143 per 105 population. Similarly, the 
CDR increased from 22% to 45%, and the TSR from 53% to 85%. The defaulter rate 
decreased from 26% to 6%. 
 
Decentralization of DOTS strategy improved the case detection and treatment success of 
TB patients. TB control programme achieved 85% treatment success; however, with the 
current low CDR (45%), the 70% WHO target seems unachievable in the absence of 
alternative case-finding mechanisms. 
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4.2. Paper II: The rate TB-HIV Co-infection Depends on the Prevalence of HIV 
Infection in a Community 
 
Limited knowledge about the rate of HIV infection in TB patients and the general 
population compromises the planning, resource allocation and prevention and control 
activities. We aimed to determine the rate of HIV infection in TB patients and its 
correlation with the rate HIV infection in pregnant women attending ANC. 
 
TB patients and pregnant women attending health facilities were enrolled in 2004 - 2005. 
TB diagnosis, treatment and HIV testing were done as per the National guideline. Logistic 
regression and linear regression analysis were used to determine the risk factors and the 
correlation between HIV infection in TB patients and pregnant women, respectively. 
 
Of the 1308 TB patients enrolled, 226 (18%, 95%CI: 15.8 - 20.0) were HIV positive. The 
rate of HIV infection was higher in TB patients from urban (25%) than rural areas (16%) 
[AOR = 1.78, 95%CI: 1.27- 2.48]. Of the 4199 pregnant women, 155 (3.8%, 95%CI: 3.2 - 
4.4) were HIV positive. The rate of HIV infection was higher in pregnant women from 
urban (7.5%) than rural areas (2.5%) [OR = 3.19, 95% CI: 2.31- 4.41]. In the study 
participants attending the same health facilities, the rate of HIV infection in pregnant 
women correlated with the rate of HIV infection in TB patients (R2 = 0.732). 
 
The rate of HIV infection in TB patients and pregnant women was higher in urban areas. 
The rate of HIV infection in TB patients was associated with the prevalence of HIV 
infection in pregnant women attending ANC. 
Improving Tuberculosis Control in Ethiopia 
 35 
Daniel Gemechu Datiko 
4.3. Paper III: Health Extension Workers Improve Tuberculosis Case Detection and 
Treatment Success in Southern Ethiopia: A Community-Randomized Trial  
 
Early case finding and prompt treatment of smear-positive cases is at the centre of DOTS 
strategy.  Unfortunately, the CDRs remain low in many countries. We aimed to find out if 
involving HEWs in TB control improves smear-positive CDR and TSR in Southern 
Ethiopia. 
 
Community randomized trial was conducted in 51 kebeles in two rural districts of 
southern Ethiopia. HEWs from the intervention kebeles were trained on how to identify 
suspects, collect sputum specimen and provide DOT.   
 
230 smear-positive patients were identified from the intervention and 88 smear-positive 
patients from control kebeles. The mean CDR was higher in the intervention than in the 
control kebeles (122·2% vs. 69·4%, p < 0·001). More females were identified in the 
intervention kebeles (149·0% vs. 91·6%, p < 0·001). The mean TSR was higher in the 
intervention than control kebeles (89·3% vs. 83·1%, p = 0·012) and for females (89·8% 
vs. 81·3%, p = 0·05).  
 
Involving HEWs in sputum collection and treatment improved smear-positive CDR and 
TSR possibly because of an improved access to the service that reduced socioeconomic 
burden on TB patients. This could be applied in settings with low health service coverage 
and shortage of health workers.  
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4.4. Paper IV: Cost and Cost-effectiveness of Treating Tuberculosis by HEWs in 
Ethiopia: An ancillary Cost-effectiveness Analysis of a Community Randomized 
Trial 
 
Increasing number of TB cases due to HIV infection and worsening socioeconomic 
conditions have affected the already overstretched health system. Therefore, alternative 
strategies that increase the effectiveness of identifying and treating TB patients at lower 
cost are required. We present the cost and cost effectiveness of involving HEWs in TB 
treatment.   
 
Comparison of two treatment options, DOT by HEWs and GHWs was done along a 
community randomized trial. Costs were analyzed from societal perspective in 2007 in 
US $ using standard methods. Cost-effectiveness was calculated as the cost per smear-
positive patient successfully treated. 
 
The total cost per successfully treated smear-positive patient was higher in health facilities 
($161.9) compared to the treatment in the community ($60.7). Community DOT (CDOT) 
reduced the total, patient and caregiver cost by 62.6%, 63.9% and 88.2%, respectively. 
The cost of involving HEWs ($8.8) was 14.3% of total cost per patient for CDOT. 
 
Involving HEWs in TB treatment is a cost-effective treatment option to health service, 
patients and caregivers. There is an economic and public health reason to involve HEWs 
in TB treatment in Ethiopia. However, due attention should be paid to ensuring initial start 
up investment to implement CDOT, resources, training and regular supervision.  
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4.5. Paper V: Tuberculosis Recurrence in Smear-positive Patients Cured Under 
DOTS in Southern Ethiopia: Retrospective Cohort Study   
  
Decentralization of DOTS has increased the number of cured smear-positive patients after 
completing treatment. However, the rate of recurrence has increased mainly due to HIV 
infection. Thus, recurrence rate could be taken as an important measure of long-term 
success of TB treatment. We aimed to find out the rate of recurrence in smear-positive 
patients cured under DOTS strategy in southern Ethiopia. 
 
We retrospectively enrolled smear-positive patients who were reported cured from 1998 
to 2006. Recurrence of smear-positive TB was used as an outcome measure. Person-years 
of observation (PYO) were calculated per 100 PYO from the date of cure to date of 
interview or date of recurrence as registered in unit TB registers. Kaplan-Meier and Cox-
regression methods were used to determine the survival and the hazard ratio (HR). 
 
368 cured smear-positive patients cured under DOTS were followed for 1463 person-
years. Of these 15 smear-positive patients had recurrence. The rate of recurrence was 1 
per 100 PYO (0.01 per annum). Recurrence was not associated with age, sex, occupation, 
marital status and level of education.  
 
High recurrence occurred among smear-positive patients cured under DOTS strategy. 
Further studies are required to identify factors contributing to high recurrence rates to 
improve disease free survival of TB patients after treatment. 
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4.5. Paper VI: Mortality in Successfully Treated Tuberculosis Patients in Southern 
Ethiopia: Retrospective Follow-up Study   
 
Tuberculosis control programme aims at identifying the highly infectious TB cases and 
successfully treat them. However, there is no routine monitoring of TB patients after 
treatment completion.We aimed to measure excess mortality in successfully treated TB 
patients.  
 
We retrospectively enrolled TB patients who were treated and reported cured or treatment 
completed from 1998 to 2006. Mortality was used as an outcome measure. Person-years 
of observation (PYO) were calculated per 100 PYO from the date of completing treatment 
to date of interview if the patient was alive or to date of death. Kaplan-Meier and Cox-
regression methods were used to determine the survival and the hazard ratio (HR). 
Indirect method of standardization was used to calculate the standard mortality ratio 
(SMR). 
 
725 TB patients were followed for 2602 person-years. 91.1% (659 of 723 patients) were 
alive while 8.9% (64 of 723 patients) had died. The mortality was 2.5% per annum. Sex, 
age and occupation were associated with high mortality. More deaths occurred in non-
farmers (SMR=9.95, 95%CI: 7.17 - 12.73).   
 
The morality was high in TB patients compared with the general population. More deaths 
occurred in non-farmers, men and elderly. Further studies are required to identify the 
causes of death in these patients. 
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Additional results  
To enrich the understanding of the context and the significance of the studies, some 
important data that were not part of the individual studies were added here. These are the 
baseline data, the duration of presentation for seeking diagnosis in the community, cases 
identified, cost of seeking diagnosis in public health facilities and treatment outcome of 
smear-negative and EPTB cases.     
 
1. Baseline data: smear-positive case detection and treatment success rates   
 
Table 1. CDR and TSR of smear-positive cases in the study area, 2003 - 2005  
Kebeles Case detection rate Treatment success rate 
  2003 2004 2005 Average  2003 2004 2005 Average  
Control kebeles 35% 53% 40% 43% 86% 91% 82% 86% 
Intervention kebeles 23% 50% 42% 38% 80% 87% 84% 84% 
Total 28% 51% 41% 40% 82% 88% 84% 85% 
 
* 3 years average TSR for smear-negative and EPTB cases was 77% and 79%, respectively. 
 
2. Duration of cough on presentation: in the intervention kebeles, of the total 723 PTB 
suspects who produced sputum for examination, more females (65%) were enrolled than 
males (35%).  Most of the suspects (75%) visited health post within 2 - 4 weeks of the 
onset of cough. The duration of cough was in the range of two weeks to six months in the 
first month of the intervention. It decreased as the sputum collection continued from the 
first month to the last month of the intervention. 
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3. smear-positive cases identified: case notification rates of smear-positive cases  
 
Table 2. Smear-positive case notification rates in the study area, 2006 - 2007  
Variable  Intervention Control Mean difference 
(95%CI) 
P - value 
CNR per 10 5  124 69 55.2 (8.4 - 102.1) 0.022 
Men  115 79 35.8 (-11.9 - 83.5) 0.138 
Women  134 65  68.5 (7 - 130) 0.030 
By season      
Spring  96 73 23.8 (- 48.2 - 95.8) 0.510 
Winter  121 40 80.9 (33.8 - 127.9) 0.001 
Autumn  79 55 23.8 (-27.1 - 74.7) 0.352 
Summer  107 48  59.3 (-1.5 -120.2) 0.056 
       
 
4. The cost of seeking diagnosis in control kebeles: household cost of seeking TB  
   diagnosis in public health facilities for smear-positive patients from control kebeles  
   accounts for the loss of about 10 working days or US$ 12.9 [10% of the GDP in  
   2007($130)], at its least estimate. This did not include the waiting time in the health  
   facilities (at outpatient department, laboratory, x-ray unit and TB room). 
 
5. Treatment outcome smear-negative and EPTB cases: Of 265 smear-negative and 
EPTB cases, 171 cases were from the intervention while 94 cases were from control 
kebeles. Of these, 75% (128/171) from intervention and 42% (39/94) from control kebeles 
were treated successfully. The TSR was higher in the intervention than control kebeles for 
smear-negative cases (p-value = 0.01). However, the TSR for EPTB cases was higher in 
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the control than intervention kebeles (p-value = 0.004). This was due to six deaths in 
EPTB cases of which four deaths occurred after admission to hospital. 
 
Table 3. Treatment outcome of smear-negative and EPTB cases in the study area, 
2006 - 2008  
 
TB Groups  Number of cases TSR* ICC** 
    Male Female Total Female Male Total   
PTB - Control  21 53 74 53% 62% 58%  
 Intervention 54 50 104 89% 82% 87% 0.0000714 
EPTB Control 13 7 20 86% 92% 90%  
  Intervention 40 27 67 74% 63% 70% 0.0000797 
 
* TSR - treatment success rate **ICC - intraclass correlation coefficient  
   NB:   the TSR was adjusted for clustering under the two treatment options. 
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6. Baseline comparison of TB cases enrolled for post-treatment follow-up   
 
Table 4. Comparison of TB cases enrolled and lost to follow-up in the study area, 
1998 - 2006        
Variables  TB patients 
followed-up n (%) 
TB cases lost to 
follow-up n (%) 
X2 p-value 
Age (mean/SD†) 26.9(13.9) 26.6(10.5) 0.2* 0.84 
sex   0.07 0.79 
    Male  379(52%) 37(53.6%)   
    Female  350(48%) 32(46.4%)   
TB classification   4.9 0.85 
    PPOS 429(59.2%) 32(46.4%)   
    PNEG 165(22.8%) 23(33.3%)   
    EPTB 131(18.0%) 14(20.3%)   
TB category   0.28 0.59 
    New  718(99.2%) 68(98.6%)   
    Others ‡ 6(0.8%) 1(1.4%)   
Treatment outcome   4.88 0.03‡‡ 
    Cured  403(55.9%) 29(42.0%)   
    Treatment completed  318(44.1%) 40(58.0%)   
  
* df = 92.3 mean difference = 0.28, † SD = standard deviation, ‡others = relapse and transfer-in 
‡‡ More cases were lost to follow-up among treatment completed (missed sputum examination at 7th month)  
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5.0. Discussion 
5.1. Discussion of the methods 
5.1.1. Study design  
The main study design was community-randomized trial in which intact social units or 
group of individuals are assigned to intervention or control groups. This study design is 
applied when individual allocation is not possible or desirable. It is a preferred design 
when an intervention involves groups is applied at the level of health organizational units 
or geographic area, is unethical to administer it to individuals, cheaper and convenient to 
administer and when reduction of contamination is required [103-106]. This design may 
be more important in developing countries, particularly in rural areas where the sense of 
community is strong, and community consent and cooperation are essential [107]. We 
conducted our study in two rural districts (Dale and Wonsho) at programme (health 
organizational unit) level using health workers in the districts (Paper III).  
 
 Cluster randomization trials lack the independence of observations and violate the main 
assumption of statistics. This influences the design and analysis; the standard approaches 
to sample size estimation and analysis no longer apply. Moreover, during recruitment, 
clusters may withdraw (in our case HEWs in a cluster may not recruit participants) which 
may lead to empty clusters. However, the shortcomings may be overcome by randomized 
allocation, increasing number of clusters (small sized clusters are more efficient), follow-
up during the intervention and adjusting for clustering during analysis. Randomization 
ensures similar distribution of known or unknown sources of bias except for a chance or a 
real effect of an intervention [104, 108-110].  
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In Paper III, we completely randomized the clusters using table of random numbers, 
adjusted for clustering and used intention-to-treat analysis that is a pragmatic approach. 
We did not have cluster level withdrawal but had three empty clusters one from 
intervention and two from control groups which reflects what happens in practice under 
programme conditions. However, this is less likely to affect the results of our study due to 
fact that we added thirty percent of calculated clusters as a contingency to compensate for 
loss to follow-up. The conduct of the study requires two level ethical consideration due to 
participant involvement at individual and cluster level [107]. We obtained informed 
consent at the two levels, from the community leaders and the patients. 
 
Cohort studies can be thought as natural experiments in which outcomes are measured in 
realistic setting [111]. Cohort studies follow two or more groups from exposure to 
outcome. It can be done ahead in time from present (prospective), in the opposite 
direction (retrospective), or in both directions. Retrospective cohort studies require good 
records of past exposure for a group of people who can be traced to find out their current 
status [112]. In Paper V & VI, TB patients who were successfully treated under DOTS 
strategy were retrospectively followed-up. The list of patients was obtained from unit TB 
registers in health facilities and this was crosschecked with the list of patients in the 
district TB register and the quarterly reports. Then the patients were traced to their place 
of residence.  
 
Cohort studies are useful to find out incidence and natural history of a disease. They allow 
estimation of incidence rates, relative risks and other outcome measures using survival 
methods. It also reduces the risk of survivor’s bias in conditions that are rapidly fatal [43, 
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112, 113]. The design is appropriate for studying rare exposures and helps to measure 
multiple outcomes that might follow an exposure. Selection bias and loss to follow-up can 
be a problem. In Paper V & VI, patients were followed to the place of their residence by 
house-to-house visit and the degree of loss to follow-up was minimal (less than seven 
percent). Cohort studies by nature are time consuming and expensive. However, the 
benefit: cost ratio of efficient cohort study is high and retrospective cohort studies  
generally reduce cost [43, 112]. In Paper V & VI, we believe that the cost of conducting 
the studies was low for we involved HEWs, used unit TB registers at health facilities and 
employed standard population for comparison of mortality.   
 
Cross-sectional study defines the scope of a problem (descriptive), identifies possible 
casual risk factors (analytic) and captures its prevalence. It is useful to generate 
hypothesis, to examine unchanging exposures (sex, blood group) that occurred many 
years back.  However, cross-sectional studies have in built ‘chicken or egg’ dilemma and 
selection bias [114]. We enrolled all TB patients and pregnant women available during the 
study period. Therefore, selection bias is less likely to affect the results. 
  
5.1.2. Validity of the studies  
The results of any research are only as good as the data upon which they are based. 
However, data may be affected by the study participants, instruments used, people’s 
memories and biological variation. As a result, no epidemiological study will ever be 
perfect except to minimize errors as far as possible, and then assess the practical effects of 
any unavoidable error [115]. The validity of epidemiological study, therefore, depends on 
the study design, the study conduct and data analysis [112]. In relation to the population 
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to which the conclusion is drawn, the term validity refers to two population groups, the 
study population (internal validity) and general population (external validity). 
 
Internal validity  
Internal validity refers to the accuracy of measuring what the study is designed to measure 
in the study participants or refers to the extent to which the results of the study reflect the 
true situation in the study sample. It is natural to take delight in interesting findings. 
However, the findings of a study could be explained by other facts than the study itself. It 
could be due to chance, bias and confounding that should be ruled out through closer 
evaluation of the study design, the selection of the study participants and the data analysis. 
The possible alternative explanations for study results are briefly discussed below.   
 
Chance (random sampling error) 
It refers to random error or the probability that variability in sampling explains the 
observed result. The role of chance is measured by conducting the test of statistical 
significance or by estimating the confidence interval. It could be reduced by taking 
adequate sample size [115, 116].  In Paper I, II, V & VI, we consecutively enrolled TB 
cases diagnosed in public health facilities employing adequate sample size.  
 
Properly conducted intervention studies reduce the probability of chance. It is assumed 
that randomization could take care of the chance occurrences of outcomes under study 
[102, 104]. In Paper III & IV, due to the random allocation of adequate number of clusters 
it is less likely that the results were affected by chance.   
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Selection bias (systematic sampling error) 
This is a systematic distortion that results from procedures used to select subjects and 
from factors that influence study participation. This occurs when study participants are 
selected inappropriately, using different criteria, or upon prior knowledge about their 
exposure or outcome. Selection bias could also arise due to self-selection of volunteers, 
ascertainment of exposure or outcome on basis of prior knowledge, one-sided low 
response rate or loss to follow-up and enrolling healthy workers. It should be considered 
and reduced in the design and conduct of a study by using a clearly defined eligibility 
criteria [112, 115, 117].  
 
In Paper I, TB patients reported over ten years were included in the study. It is possible 
that poor outcomes might not be reported. However, the treatment outcome data was 
crosschecked against the previously reported case finding which was used to calculate the 
treatment outcomes. In addition, only about 4% of all TB cases were not evaluated for 
which incomplete recording could be one of the reasons [118]; in one of the zones in the 
region, as high 17.5% of TB cases were not evaluated and treatment was not registered for 
them[119]. TB patients were prospectively (Paper III & IV) and retrospectively (Paper V 
& VI) followed to their place of residence. In Paper V & VI, the list of patients was 
obtained from the TB unit registers available in the health facilities where the patients 
received treatment; in this case the registration was less likely to be affected by the 
outcomes of the cases.  In Paper II, we consecutively enrolled all TB patients and 
pregnant women available during the study period. Therefore, it is less likely that the 
results are affected by selection bias. However, ecological fallacy could be a problem for 
we used aggregate data of few study sites to estimate the correlation (Paper II).  
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In intervention studies, participants lost to follow-up and protocol deviation can occur at 
the level of the cluster (cluster withdrawal or lost to follow-up or inactive cluster) or the 
individual (participant withdrawal or lost to follow-up, or transfer from one cluster to 
another). However, this could be improved by regular follow-up and by intention-to-treat 
analysis [110]. In Paper III and IV, there was no cluster level withdrawal and individual 
level loss to follow was minimal to affect the comparability of the groups. Moreover, 
analysis using cluster as unit of analysis and cluster level values maintains comparability 
of the groups.  
 
In Paper V, we found that no baseline difference between the cases enrolled in the study 
compared to those who were lost to follow-up and moved to other places except in the 
difference in treatment outcome (additional results - 6, table - 4). However, there was no 
difference in mortality and recurrence among those who were reported cured or treatment 
completed (Paper V & VI).   
 
Information (measurement) bias 
It is a systematic error that results from systematic differences in the way exposure or 
outcome data are obtained. This can be reduced by using eligibility criteria, defined 
exposure or outcome, objective and structured questionnaire and maintain blinding of the 
participants to exposure or outcome. In addition, implementation of standardized training 
using written protocol, administering the data collection under uniform conditions, 
conducting regular supervision and quality check could reduce information bias  [117].  
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In our studies, standard case and treatment outcome definitions, laboratory examination 
method, registers and reporting formats were used. GHWs and laboratory technicians 
were trained. CHRL prepared reagents for sputum examination and distributed to the 
districts. Slides were collected for quality control to assure the quality of the tests as per 
the recommendation of NTLCP (CHRL reported 98% concordance with the slides from 
the peripheral laboratory in the study area). In addition, TB control programme experts 
and the investigator supervised the health facilities to follow the conduct of the studies. 
The data about rediagnosis was confirmed by cross-checking the report against unit TB 
registers in health facilities (Paper V). The diagnosis of smear-negative and EPTB had a 
component of subjective decision by the clinicians. However, the use of uniform training 
materials and case definitions based on the NTLCP guideline and working under similar 
setting (GHWs and the health facilities providing diagnostic service) could reduce the 
effect of subjective decision.  
 
In the cost-effectiveness study (Paper IV), we included smear-positive cases diagnosed 
during the study period. The travel time and related costs were cross-checked against the 
travel distance and existing market price by the HEWs and GHWs who know the 
estimates of travel time and related costs. The fact that we did not give incentives or 
refund the expenses makes the estimate reasonable for the travelled distance and related 
expenses.  Thus, we believe that the measurements were less prone to bias to significantly 
affect the study results.    
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Confounding  
It refers to a mixing of effects that can occur when the results of a study are confused by 
effect of a third factor that is associated with both the exposure and the outcome but not 
an intermediate between them. Confounding occurs when a confounding variable is 
distributed unevenly across study groups and can lead to either overestimation or 
underestimation of the effect size, completely hide and in extreme cases reverse the 
direction. This is a major problem in observational studies and in some non-randomized 
trials if they are small. In such cases, increasing the size of the study does not make any 
difference to the size of confounding. However, it can be reduced at design stage by 
randomization, matching and restriction; and at stage of analysis by stratification and 
multivariable modelling [112, 115, 117, 120, 121].  
 
In our studies, randomization (Paper III & IV), multiple logistic regression (Paper II) and 
Cox proportional hazard regression (Paper V & VI) were done to control for confounders. 
Randomization deals not only with confounders that are known and can be measured but 
also with other unrecognizable or unmmeasurable confounders in the study group that 
makes the results less likely to be affected by confounding except for the play of chance. 
In addition, in the analysis, we stratified the data by age, sex, residence, TB classification 
and category (Paper II) and by sex, level of education, marital status, occupation and TB 
classification (Paper V) to control for confounders in the analysis. However, in Paper II, 
using aggregate data made it difficult to control for confounding factors. Generally, if 
confounding is not evaluated, invalid and potentially dangerous results could be 
extrapolated to the study and general population [121] while controlling for cofounding 
ensures the internal validity of the study, a prerequisite for external validity.  
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External validity (Generalizability)  
It refers to the applicability of the results to the people outside the study population. The 
applicability of the study results outside the study setting depends on the feasibility of 
conducting it under routine care and its acceptability [122]. In addition, using broader 
eligibility criteria increases the applicability of the findings to a wider population [123].  
 
The results of Paper III could be applied in settings with low health service coverage (low 
DOTS coverage and limited number of TB laboratories), where HEWs have the first 
contact with the people to provide health education, and collect and transport sputum 
specimens and provide DOT. It is considered that, this makes the service patient-centred 
and improve the case finding and treatment adherence [124]. The study area is a densely 
populated agrarian community, typical of the rural population on the Ethiopian highlands. 
It could also be applied in areas with a shortage of health workers, especially laboratory 
technicians, with or without adequate health service coverage.  
  
In the studies, we used the existing health service (health centres and health posts) and 
health workers (GHWs and HEWs) within the policy provision of community-based 
initiative. The study employed the routine TB care and decentralized service to the 
community without requiring the patients to make extra visits for the purpose of the study. 
This reduced the distance travelled by the patients and caregivers, travel time and related 
expenses. This might have increased the time for productivity by caregivers and possibly 
by the patients.  
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We believe that it was acceptable by the community as the patients received treatment 
under direct observation of HEWs (a member of their kebele) at health post in the kebele 
(the closest health facility to their living place) and possibly culturally acceptable as the 
patients did not travel out of their kebeles and were treated by HEWs who understand the 
culture and speak their language. Moreover, the improved TSR for smear-negative and 
EPTB add to the applicability of the intervention to all forms of TB (additional results - 5, 
table - 3). However, TB patients should be carefully evaluated for their general condition 
at diagnosis and during follow-up. Generally the implementation of our intervention in 
different kebeles with different TB incidence, prevalence and varying performance of TB 
control programme makes it more applicable.  
 
The intervention required initial investment to start community-based TB care. But, 
compared to the benefits of improving case finding, reducing disease transmission and 
improving the treatment outcome; and cost implication to the patients, households and the 
health service, the researchers strongly believe that it is valid to apply to broader 
population. The results of the study could be applied in settings with limited health 
service coverage and shortage of health workers including laboratory technicians, which 
exists in many developing countries. The implementation should be done step-by-step to 
learn from the experience and improve its performance by dealing with emerging 
challenges. 
  
5.2. Discussion of main findings 
Decentralization of TB control programme to peripheral health facilities increased access 
to the service and increased the number of cases identified and treated. In our study area, 
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involving HEWs in TB control improved the case detection and treatment success rates. It 
was also economically attractive for the patients, the household and the health service. 
This is one of the ways to overcome the challenges of the TB control programme in 
settings with low health service coverage and shortage of health workers in the face of 
HIV epidemic.   
 
5.2.1. The role of general health workers in health facility DOT   
The introduction of DOTS strategy, in response to the increasing global burden of TB, is 
an important landmark in the history TB control. DOTS strategy aims to detect 70% of 
incident smear-positive cases and cure 85% of them through early case finding and 
providing prompt treatment.  
 
The implementation of DOTS strategy was started in hospitals followed by 
decentralization to peripheral health facilities and later involved all care providers and the 
community. Decentralized implementation of the DOTS strategy has successfully 
improved the TSR of smear-positive cases. However, its effectiveness in CDR was 
limited mainly due to low health service coverage, shortage of health workers, HIV 
epidemic, MDR TB and inadequate involvement of the available care providers [19, 124-
127]. In Paper I, decentralization of DOTS to peripheral health facilities increased the 
TSR from 53% to 85%. However, its effectiveness in improving the CDR was limited; it 
increased from 22% to 45%, far below the target to effectively reduce the incidence of 
smear-positive cases [14]. Similarly low CDR was reported in a study conducted in rural 
districts of southern Ethiopia. However, the possible explanations given were treatment of 
adequate number of TB cases by the  decentralized implementation of DOTS that reduced 
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the incidence and prevalence of TB or low disease burden in the study area [119]. 
However, our findings suggested that backlog of cases were not adequately reached by the 
DOTS strategy to reduce the incidence and prevalence of TB due to the prevailing low 
health service coverage and its utilization.  
 
Moreover, TB diagnosis and treatment was limited to health centres and hospitals. In such 
cases, TB suspects and patients travel long distance; have out of pocket expense and loss 
of productivity to seek diagnosis and treatment. This could be improved by creating 
awareness about TB in the community. However, this can also have impact on case 
finding if optimally functioning diagnostic and treatment facilities are available within the 
reach of the community. It is therefore required of TB control programme to identify 
alternatives that reduce the cost of the health service and the community to access the 
service. The contributions of the community health workers specifically HEWs in our 
settings are discussed below.   
 
5.2.2. Community involvement in TB control   
Community participation and contribution to health system was recognized as an essential 
element of public health interventions and primary health care [128]. After long silence, 
the following reasons called for renewed interest to look for cost-effective alternatives to 
deliver diagnostic and treatment services to TB patients. Decentralization of TB services 
did not increase the access to the services as expected mainly because of inadequate 
health service coverage, insufficient decentralization of both diagnostic and treatment 
services and shortage of health workers and resources. This was worsened by the 
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increased burden of TB that overstretched the existing health services in many countries 
[69, 129].  
 
In Ethiopia the main challenge for NTLCP continues to be low CDR. Attempts to increase 
CDR through deploying HEWs and training GHWs to identify and refer suspects has not 
yet demonstrated an increase in CDR. This suggests the existence of problems in the 
health system that needs alternative approaches to improve the programme performance 
[130]. 
 
Community-based case finding    
TB diagnosis depends on examination of patients that visit health facilities. However, the 
awareness about TB, socioeconomic status, culture, access to the health service, the 
quality of the service and the interplay among these factors affect the health seeking 
behaviour of the community. Cognizant of the interplay between these factors, TB 
diagnosis was primarily considered to be the role of GHWs. However, evidences show 
geographic expansion DOTS strategy to have less effect on improving case finding [125]. 
Similarly, in our setting (Paper I), DOTS expansion (treatment and diagnostic units) 
improved the TSR while the CDR remained far below the target.    
 
To improve the CDR in our setting, the role of community in TB case finding that 
involves activities such as raising awareness of TB, advocacy for adequate resources and 
proper care, identification and referral of TB suspects and supporting patients during 
treatment was revisited [14]. In Paper III, we involved HEWs in identifying PTB suspects, 
sputum collection and transportation to diagnostic units and administration of DOT. This 
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has successfully increased the CDR in the intervention group (122%) compared to the 
control group (69%). The main reasons were increased access to diagnostic facilities that 
was created (by sputum collection in the kebeles and its transportation to diagnostic units 
by HEWs). The intervention improved geographic and economic access to the rural 
community. In addition, more women suspects were examined (additional results - 2) and 
more smear-positive cases were detected among them. This could be one of the 
explanations why less women TB cases are reported in DOTS strategy. We believe that 
our intervention addressed socio-cultural and economic factors that affected the heath 
seeking behaviour of women. In addition, for every smear-positive case detected in health 
facilities existed two undetected smear-positive cases in the community. Though, 
attractive the case fining is the adherence of the patients to treatment and the cost 
effectiveness of involving HEWs in TB control should be clearly outlined.  
 
Community-based DOT 
DOT is only one range of measures aimed at promoting treatment adherence. Thus, the 
fight against TB, a scourge to humanity, requires a concerted effort of the health system, 
care providers and the community. This presupposes a patient-centred service that is 
easily accessible, convenient and acceptable without compromising the treatment success. 
To this end a range of community members, TB patients, families, community leaders and 
CHWs were involved in providing DOT. Community DOT was found to be as effective 
as the health facility based DOT [126, 131-133]. The study (Paper III) has shown 
community DOT - treatment by HEWs to be more effective than the health facility DOT 
in our setting. The TSR was 89% in the community and 83% under health facility DOT. 
In addition, the rate of defaulter, failure and transfer out was low in the community-based 
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approach. This could be mainly due to the improved geographic and socioeconomic 
access created by providing DOT in the community.  
 
Cognizant of the argument that treatment success should be improved prior to increasing 
the case detection, except for improving the TSR the effectiveness of CHWs in improving 
the CDR was limited [133, 134]. This could be due to the fact that the role of CHWs was 
limited to improving treatment adherence and providing health education. Is this a failure 
of DOTS strategy? [127] In our study, we have explored option of involving HEWs in 
sputum collection and improved the CDR. However, the cost-effectiveness of involving 
HEWs in sputum collection required further study. 
 
Cost-effectiveness of community DOT 
Health interventions of public health importance should be cost-effective. This is of most 
use in situations where a decision maker, operating with a given budget, is considering a 
limited range of choices within a given field.  
 
Studies show that involving CHWs in providing DOT is a cost-effective alternative for 
economic reasons for the patients, household and health service. Compared to health 
facility DOT, community DOT is effective without compromising the TSR [135-138]. 
But, its cost-effectiveness varied with the type and the role of the CHWs involved in 
community-based approaches, the health service coverage and other related factors [139-
144]. In Paper IV, the cost per successfully treated smear-positive patient in the 
intervention area ($61) was lower compared to health facility DOT ($162). It reduced the 
cost per successfully treated smear-positive case by 63%. For the same amount of cost of 
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treating a patient in health facilities more than two patients could be treated in their 
communities. This was due to the decentralization of the service and reduced the travelled 
distance and time and associated costs for seeking treatment.  
 
In addition, the high cost incurred for seeking diagnosis in public health facilities ($13, 
about 10% of GDP loss or loss of 10 working days) could also be one of the reasons for 
low CDR at its least estimate excluding the cost related to visits made to other health 
facilities and traditional healers ( additional results 4). Other studies reported that the cost 
of seeking diagnosis to be prohibitively high for the patients and their household [47-51].  
In this study, stronger belief is held that community-based sputum collection has reduced 
the cost of seeking diagnosis in public health facilities due to the reduced travel distance, 
time and related costs.  
 
As cost-effective as it may be, implementation of community DOT at larger scale was 
limited  due to high turnover and/or exhaustion of the CHWs, additional cost incurred to 
run community-based programme and lack of sustainability [124, 133]. Hence, 
community-based efforts to control TB should be patient centred, sustainable and 
integrated into the general health service in such a way that it complements the existing 
health service delivery.  
 
In Paper III & IV, involving HEWs improved the CDR and TSR and was cost-effective 
compared to the health facility DOT. The health workers involved in our study operated 
under the provision of the health policy of the country, employed and received salary and 
supervised by public health professional in health centre. In addition, two HEWs were 
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assigned in each kebele and training schools deploy new graduates to address the attrition 
[145]. This ensures the sustainability of involving HEWs in TB control in Ethiopia. 
 
5.2.3. Long term efficacy of DOT 
Effective disease control strategy should be efficient in identifying the cases early, 
providing prompt treatment and ensuring long term disease free survival of the patients. 
Therefore, understanding the long term efficacy of the DOTS strategy in reducing the rate 
of recurrence (either due to relapse or reinfection) [146-150], mortality, development of 
MDR TB and its effectiveness in the face of HIV epidemic and socioeconomic 
deprivation is crucially important [151-156].  
 
In Paper V & VI, we found high recurrence rate and mortality among successfully treated 
TB patients. The plausible explanations were HIV infection, MDR TB and possibly 
continued transmission due to high backlog of untreated cases in the community. In Paper 
II, the prevalence of HIV infection in the community was 3.8% and the rate of TB-HIV 
co-infection was 17.5%. This is high enough to affect the survival of TB patients after 
successful treatment.    
 
Moreover, we reported excess mortality (Paper VI) in TB patients after successful 
treatment. The mortality was higher in non-farmers (SMR=9.95, 95%CI: 7.17 - 12.73). 
This could also be explained by HIV infection and to some extent by prevalence of MDR 
TB. Thus, TB control programmes should strengthen patient follow-up, provide HIV 
counselling and testing for TB patients during follow-up period and after successful 
treatment. This requires decentralized implementation of provider initiated HIV 
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counselling and testing for TB patients that is performing in limited health institutions. 
Less than five percent of TB patients were tested for HIV during the study period which 
has now increased by three fold [21]. Further study is needed to estimate the prevalence of 
MDR TB and causes of death in successfully treated TB patients.  
 
Strategies that enhance TB-HIV collaboration activities are needed in such settings. All 
TB patients should be encouraged to be tested for HIV and enrolled for antiretroviral 
treatment and management of other opportunistic infections. HIV negative TB cases 
should also be advised to reduce their risk and be encouraged to live HIV free life. The 
health facilities should organize their facilities in such a way that it encourages simple 
patient flow and convenience.  
 
In addition, the role of the community and HEWs in prevention and control of the two 
diseases should be clearly outlined and implemented. This should be accompanied by 
decentralization and scaling up of DOTS strategy and provision of antiretroviral 
treatment. This will increase the number of patients accessing and receiving the service to 
benefit from the available treatment that will contribute to the long term efficacy of DOTS 
strategy.      
 
We demonstrated the significance of community-based intervention in TB control within 
the existing health system in Ethiopia. The recommendations of our study were taken up 
by the Federal Ministry of Health of Ethiopia. The SNNPRS Health Bureau required 
larger scale implementation of the community-based TB care to provide evidence-based 
Improving Tuberculosis Control in Ethiopia 
 61 
Daniel Gemechu Datiko 
decision making for policy change to make sure that the benefits of the study were shared 
by TB patients, the community and TB control programme of the country.  
 
We therefore recommend further larger scale intervention to strengthen the health system 
and improve the performance of the NTLCP of Ethiopia through community-based 
approaches based on evidences from the field.  In such cases, health system strengthening 
should also be part of the intervention where the GHWs and HEWs will receive adequate 
training and necessary resources made available. The service should then be progressively 
scaled up and based on the lessons learned should be used to improve the model of the 
implementation. This should also be accompanied by monitoring and evaluation of the 
impact and quality of the community-based approach to improve the role of HEWs and 
the community in TB control.   
 
The NTLCP has recognized the role of HEWs in TB control and decided to start case 
finding and treatment by HEWs. The WHO in collaboration with the NTLCP has started a 
pilot project of implementing community-based case finding through referral of suspects 
and decentralization of treatment to health posts under the direct observation of HEWs in 
four big regions of the country. Currently the Federal Ministry of Health of Ethiopia has 
accepted the implementation of community-based TB care by employing HEWS in 
referring suspects and encouraging adherence to treatment. National guideline for 
implementing community-based TB care was developed to start implementing the service 
at larger-scale. 
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6.0. Conclusions and recommendations  
 6.1. Conclusions  
1. Decentralization of DOTS strategy to peripheral health facilities improved the 
CDR and TSR under the observation of GHWs  
2. The rate of TB-HIV co-infection is high and is associated with the prevalence of 
HIV infection in the community 
3. Beyond achieving the treatment success rate of 85%, the recurrence and mortality 
rate was high in successfully treated TB patients. Therefore, identifying the causes 
of recurrence and death is important to ensure disease free survival of TB patients. 
4. Involving HEWs in community-based case finding and treatment of smear-
positive TB cases improved the CDR and TSR. More women smear-positive cases 
were identified and treated in the community-based approach. 
5. Involving HEWs in TB treatment is cost-effective and increased the number of 
treated TB cases for the same amount of cost under health facility DOT. This is 
economically attractive option for the patients, households and the health service. 
 
6.2. Recommendations 
6.2.1. Clinical practice 
1. GHWs should be trained about identifying TB cases that require closer follow-up 
in health centres and hospital before referring them for treatment in the community 
under HEWs and vice versa.  
2.  HEWs should be trained about identifying seriously ill TB patients and patients 
with side effects that need referral and follow-up in health centres and hospitals. 
Improving Tuberculosis Control in Ethiopia 
 63 
Daniel Gemechu Datiko 
3. GHWs and HEWs should inform TB patients to be tested for HIV during 
treatment and even after completing treatment to benefit from the available care.  
4. TB patients should be advised to seek medical care if they develop symptoms of 
TB after completing treatment.  
 
6.2.2. Public health implications 
1. Decentralization and implementation of DOTS strategy should be accompanied by 
regular monitoring and evaluation of its performance. 
2. Routine TB data reported from districts to higher levels should be analysed and 
utilized locally to improve the performance of TB control programme in the 
districts. 
3. Regular surveillance of  HIV prevalence, TB-HIV co-infection and MDR TB 
should be incorporated into TB and HIV Prevention and Control Programmes 
4. Early identification and prompt treatment of smear-positive TB cases should be 
emphasized to reduce the risk of transmission in the community 
5. Supportive supervision should be strengthened to improve the performance of 
community-based interventions as part of strengthening the delivery of health 
service to the community. It should be clearly outlined and practiced at all levels.  
 
6.2.3. Future research 
1. Conduct a community-based smear-positive prevalence survey to estimate the 
burden and the impact of the interventions on the incidence and prevalence of 
smear-positive TB 
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2. Determine the causes of recurrence in smear-positive cases after successful 
treatment under DOTS  
3. Estimate the cost-effectiveness of community-based sputum collection in 
improving case finding of smear-positive cases.   
4. Determine the causes of death among successfully treated TB patients to better 
estimate mortality related to TB   
5. Evaluate the significance of community-based case finding and treatment at larger 
scale as an integral part of strengthening the health system of the country.  
 
6.2.4. Policy   
1. The role of HEWs in TB case finding and treatment should be clearly stated and 
its implementation should be supported by measurable indicators to increase the 
contribution of the HEP in the efforts to prevent and control TB in Ethiopia 
2. In collaboration with the HEP, the NTLCP should incorporate the role of HEWs in 
TB control. This should be supported by including it in the NTLCP guideline and 
implementation documents specifically prepared for HEWs. 
3.  Community-based DOT is cost-effective intervention in an effort to reduce the  
diseases burden and save lives, worth adopting in resource constrained settings 
4. Community-based DOT is cost-effective intervention. However, it is not without 
cost. Therefore, initial investments related to involving HEWs in TB control 
should be clearly identified and planned before embarking on scaling it up 
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Annexes  
I. CASE FINDING FORMAT  
 
 
 
Quarterly report on tuberculosis case-finding
  Zone
Region: Zone: Woreda:
Name of Co-ordinator: Date: Signature:
Pulmonary tuberculosis Extra-
Smear positive Smear pulmonary
New cases Relapses Failures Defaulters negative TB All All Grand
M F Total M F M F M F M F M F male female total
         0 - 14         15 - 24         25 - 34         35 - 44         45 - 54         55 - 64         65+ All All
M F M F M F M F M F M F M F male female
pos neg not done
LCC LCC
Quarter during which patients were registered:                 Quarter
        WoredaLevel of report (tick on the appropriate box):                      Region
TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME ETHIOPIA
       Year (EC)
ALL CASES REGISTERED DURING THE QUARTER:
SMEAR POSITIVE NEW CASES BY AGE AND SEX:
DURING THE PREVIOUS QUARTER
Total
Totals
New 
cases
2 month smear result
SMEAR CONVERSION AT 2 MONTHS OF
NEW SMEAR-POSITIVE CASES PUT ON SCC 
SCC SCC
NUMBERS OF NEW SMEAR POSITIVE 
CASES PUT ON SCC OR LCC: EPTB CASES PUT ON SCC OR LCC
NUMBERS OF NEW SMEAR NEGATIVE AND
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II. TREATMENT OUTCOME FORMAT  
Patients registered during quarter: Year (EC):
Region: Zone: Woreda: Date:
Name of Co-ordinator: Function Signature:
PTB SMEAR POS PTB SMEAR NEG EPTB
SCC
LCC
SCC
LCC
SCC
LCC
COMMENTS:
Date received by TLCT:
* if number evaluated is less than no.registered, comment
TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME ETHIOPIA
Quarterly report on the results of treatment of all TB patients registered 13 - 15 months earlier
Regimen Transferred     
out
Total number 
evaluated*
Total number of new patients registered during the quarter being reported:
Total number of cases registered for re-treatment during the reported quarter:
Cured Died DefaultedFailureTreatment 
completed
Number 
registered
Re-treatment
New cases 
PTB-POS.
New cases 
PTB-NEG.
New cases 
EPTB
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III. UNLINKED ANONYMOUS SEROSURVEY IN TB PATIENTS  
 
Study site ______________        
Date ___________  
Patient code no _______________  
Age __________  
Sex __________ 
Address      Urban ___________ Rural _______________ 
Diseases category    a) New      b) Relapse       c) treatment after default  
Disease classification   a) PTB+ve   b) PTB -ve    c) EPTB  
 
 
Name of responsible health worker ________________ Signature ____________ 
 
Note: From ANC surveillance format we included study site, date, client code, age, sex 
and address as variables for paper II.
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IV. CHECKLIST OF SYMPTOMS IN TB SUSPECTS IN THE COMMUNITY   
 
Questionnaire no.________ Name of interviewer __________ Date___________________ 
 
 
1. Socio-demographic variables  
 
1.1 Name of suspect ____________________ 1.2. Age________1.3. Sex _____________ 
 
1.4. Cluster __________ Kebele _________Residence urban _____ rural ______________ 
 
1.5. Marital status  Single___________ Married__________ Divorced________________ 
 
Widowed________ other (specify) ____________________________ 
 
1.6. Educational status   No schooling ____ Grade ____   other (specify) ______________ 
 
1.7. Occupation of suspect   Farmer ____ student ____   merchant ____________ ______ 
 
 House wife ________government employee____________ _______ 
 
 daily labourer__________ others (specify) _____________________   
 
2. Tuberculosis symptoms and history 
2.1. Did you experience cough for two or more weeks?      Yes __________  No  ________ 
 If yes, for how many weeks _________ 
2.2. Is the cough productive of sputum?      Yes __________  No  ________ 
 If yes, does it contain blood?       Yes __________  No  ________ 
2.3. Did you have fever and night sweats?      Yes __________  No  ________ 
 If yes, for how many weeks _________ 
2.4. Did you have loss of appetite?       Yes __________  No  ________ 
 If yes, for how many weeks _________ 
2.5. Did you loss weight?        Yes __________  No  ________ 
2.6. Did you have chest pain?       Yes __________  No  ________ 
 If yes, for how many weeks _________ 
2.7. Did you have shortness of breath?                   Yes _________  No  ________ 
 If yes, for how many weeks _________ 
2.8. Did you have history of tuberculosis treatment?     Yes __________  No  ________ 
2.9. Did you have closer contact with known TB patient?    Yes __________  No  ________ 
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V. LABORATORY REGISTER  
Month(s): Year:
1 2 3
LABORATORY REGISTER FOR AFB
Patient 
number
Hea lth 
Unit
Lab. 
Seria l 
number
Name  and address 
of pa tient
Name  and address 
of contact pe rsonDate Age Sex Sign Remarks
New 
pa tient
Follow-
up
Woreda  
T B/Lep 
number
Results
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   VI. UNIT TB REGISTER - INTENSIVE PHASE TREATMENT  
Days:
Mth 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
Intensive phase treatment monitoring chart
Lab. no.
Weight
Age P/Pos, P/Neg 
or EP
Drug Dose
Unit  TB 
Number Name (in full) and 
address of patient
Sex 
M/F
Intensive 
phaseName and 
address of 
contact personWoreda 
TB No.
Smear 
result
Category 
N.R.F.D.T.O
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  VII. UNIT TB REGISTER - CONTINUATION PHASE TREATMENT 
Ha m Ne h Pa g Me s T ik Hid T ah T ir Ye k Me g Mia Gin Se n
2nd 
month
5th 
month
7th/11th 
month
Drug Dose
Month:
   Sputum re sults,  
la b.name , seria l nr.& wt
Continua tion 
phase
Continua tion pha se  trea tme nt monitoring cha rt
4 - we e kly a tte ndance : RemarksCured T re atme nt comple te d Die d Fa ilure De fa ult
T ransfer 
out:       
name of unit
Da te  tre a tme nt stoppe d (e nte r da te  in appropria te  column):  
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VIII. COST OF TB TREATMENT - INTENSIVE PHASE  
 
Cost items for intensive phase treatment for TB  patients        
Questionnaire number     Name of interviewer   
Background                       
1. Name of TB case            
2. Age                       
3. Sex                        
4. Kebele                       
5. Religion                    
6. Marital status                      
7. Educational status                         
8. Occupation                    
Cost of TB case                       
  date means of transport 
travel 
time in 
minutes 
travel 
cost 
type of 
meal cost 
type of 
drinks cost  
accommodation  (if stayed 
overnight) 
Visit to GHWs or HEWs place 
amount  
paid reason 
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                     
                     
             
Cost of companion                      
Visit to GHWs or HEWs                       
  date 
means of 
transportati
on 
travel 
time in 
minutes 
travel 
cost 
type of 
meal Cost 
type of 
drinks Cost  
accomodation  (if stayed 
overnight)  
  place amount paid reason 
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IX. COST OF TB TREATMENT - CONTINUATION PHASE   
 
Cost items for continuation phase treatment for TB  patients        
Questionnaire number     Name of interviewer   
Background                       
1. Name of TB case            
2. Age                       
3. Sex                        
4. Kebele                       
5. Religion                    
6. Marital status                      
7. Educational status                         
8. Occupation                    
Cost of TB case                       
  date means of transport 
travel 
time in 
minutes 
travel 
cost 
type of 
meal cost 
type of 
drinks cost  
accommodation  (if stayed 
overnight) 
Visit to GHWs or HEWs place 
amount  
paid reason 
                    
                    
                    
                    
                    
                    
                    
                    
                    
                    
                     
                     
             
Cost of companion                      
Visit to GHWs or HEWs                       
  date 
means of 
transportati
on 
travel 
time in 
minutes 
travel 
cost 
type of 
meal Cost 
type of 
drinks Cost  
accomodation  (if stayed 
overnight)  
  place amount paid reason 
                    
                    
                    
                    
                    
                     
                     
                    
                    
                    
                    
                     
                     
 
Note: Use extra sheet for more than one care takers 
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X. COMMUNITY-BASED POST-TREATMENT FOLLOW-UP FORMAT 
Questionnaire no.________ Name of interviewer ______________________ 
Date______/_______/________  
Socio-demographic variables during past treatment  
1. Name of TB patient___________________  2. Sex ___________   
3.  Age at first diagnosis ___________  4. Kebele  ______________  
5.  Health facility _______________________  6. TB unit register number ___________ 
7. TB classification  PTB +ve __________   PTB -ve _________  EPTB ________ 
8. Treatment category New ____ Relapse _____ Failure ____ Defaulter ____ others ___ 
9. TB treatment regimen   ______________________________________________ 
10. Date treatment started  _____/_________/________  
11. Treatment outcome Cured __________   Treatment completed __________ 
12. date treatment completed _____/_________/________ 
Current sociodemographic character after completing treatment for TB 
1. Current condition   Alive ______  Dead ______  Date of death _____/______/______ 
2. Marital status Single___ Married___ Divorced___ Widowed____ other___________ 
3. Educational status   No schooling ____ Grade ____   other _____________________ 
4. Occupation of suspect   Farmer ____ student ___  merchant ___others ____________ 
History related to tuberculosis after first treatment for TB 
1. History of diagnosis for TB Yes ____ No ____ 2. Health facility _________ 
2. TB classification PTB +ve __________   PTB -ve _________  EPTB ________ 
3. TB category New ____ Relapse _____ Failure ____ Defaulter ____ others ________ 
4. Date treatment started ____/___/____ 5. Date treatment completed ____/___/_____ 
6. Treatment outcome Cured ___Completed ___ Died ___ Failure __ Default __ TO  ___ 
7. History of cough  Yes____ duration in months _______ 
Note: 1. Collect sputum specimen for patients with productive cough of two weeks or more  
           2. Advise and refer patients who have other medical conditions  

